[1]Neeraj Shah,Min Qian,Marco R. Di Tullio,Susan Graham,Douglas L. Mann,Ralph L. Sacco,Gregory Y. H. Lip,Arthur J. Labovitz,Piotr Ponikowski,Dirk J. Lok,Stefan D. Anker,John R. Teerlink,John L. P. Thompson,Shunichi Homma,Ronald S. Freudenberger,the WARCEF Investigators.Pulse pressure and prognosis in patients with heart failure with reduced ejection fraction[J].European journal of clinical investigation,2019,49(6):e13092.

[2]Hoekstra Tialda,Lesman-Leegte Ivonne,van Veldhuisen Dirk J,Sanderman Robbert,Jaarsma Tiny.Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction[J].European journal of heart failure,2011,13(9):1013-1018.

[3]Sara Rovai,Ugo Corr,Massimo Piepoli,Carlo Vignati,Elisabetta Salvioni,Alice Bonomi,Irene Mattavelli,Luca Arcari,Angela B. Scardovi,Pasquale Perrone Filardi,Rocco Lagioia,Stefania Paolillo,Damiano Magrì,Giuseppe Limongelli,Marco Metra,Michele Senni,Domenico Scrutinio,Rosa Raimondo,Michele Emdin,Carlo Lombardi,Gaia Cattadori,Gianfranco Parati,Federica Re,Mariantonietta Cicoira,Giovanni Q. Villani,Chiara Min,Michele Correale,Maria Frigerio,Enrico Perna,Massimo Mapelli,Alessandra Magini,Francesco Clemenza,Maurizio Bussotti,Elisa Battaia,Marco Guazzi,Francesco Bandera,Roberto Badagliacca,Andrea Di Lenarda,Giuseppe Pacileo,Aldo Maggioni,Claudio Passino,Susanna Sciomer,Gianfranco Sinagra,Piergiuseppe Agostoni.Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid‐range ejection fraction[J].European journal of heart failure,2019,21(12):1586-1595.

[4]Observation of long-term prognosis of patients with heart failure with reduced left ventricular ejection fraction and heart failure with preserved left ventricular ejection fraction[J].Journal of Internal Intensive Medicine

[5]Josep Lupón,Carles Díez‐López,Marta de Antonio,Mar Domingo,Elisabet Zamora,Pedro Moliner,Beatriz González,Javier Santesmases,Maria I. Troya,Antoni Bayés‐Genís.Recovered heart failure with reduced ejection fraction and outcomes: a prospective study[J].European journal of heart failure,2017,19(12):1615-1623.

[6]LIU Lin,DIAO Yunhui,LI Hui,LI Jun,ZHANG Kai,SHEN Wenyu.The value of peak oxygen uptake in predicting prognosis in patients with heart failure with not reduced ejection fraction[J].Journal of Cardiovascular and Pulmonary Diseases,2020(1):6-8.

[7]WANG Hao,LI Xia,LIN Liang-yi,WANG Ping,LIN Shao-hua.The prognosis evaluation of serum procalcitonin levels in heart failure patients with preserved ejection fraction[J].Journal of Bengbu Medical College,2015,40(3):348-350.

[8]Cheng Zhongwei,Zhu Kongbo,Chen Taibo,Gao Peng,Cheng Kang'an,Fang Ligang,Deng Hua,Zhu Wenling,Fang Quan.Poor prognosis in chronic heart failure patients with reduced ejection fraction in China[J].Congestive heart failure (Greenwich, Conn.),2012,18(3):165-172.

[9]LI Bing,CHEN Hai-yan,FENG Yong-li,WANG Long-an,CHU Ying-jie.Follow - up study on life quality and prognosis of heart failure patients with reduced and normal left ventricular ejection fraction[J].Central Plains Medical Journal,2011(21):1-2,6.

[10]WANG Qi,AI Chang-hong,SHANG Qing-hui.Study progress in pharmacotherapy against heart failure with reduced ejection fraction[J].Chinese Journal of Hospital Pharmacy,2018,38(7):796-800.

[11]New therapeutic options for patients with heart failure with reduced ejection fraction and acute decompensated heart failure[J].Advances in medical sciences

[12]DENG Chun-rong%FAN Hong-wei.The prognostic value of QRS duration in heart failure patients with reduced ejection fraction[J].Chinese Journal of Cardiovascular Review,2013,11(5):341-344.

[13]Liu De-Ping,Wang Fan,Zeng Xue-Zhai,Zhang Xin-Chao.Clinical characteristics and prognosis of heart failure with normal left ventricular ejection fraction in elderly patients[J].Chinese medical journal,2012,125(16):2853-2857.

[14]WAN Yiming,SANG Haiqiang,DONG Jianzeng,JIA Yuchen,MA Huihui,JIANG Yaohui.Pharmacoeconomic evaluation of empagliflozin in the treatment of heart failure with reduced ejection fraction[J].China Pharmacy,2022(1).

[15]刘士立,赵丽,苗利辉.Study in clinical data from heart failure patients with preserved and reduced ejection fraction[J].Chinese Journal of Emergency Medicine,2016(10):1296-1300.

[16]Qian Gao,Shan He,Yuanshu Peng,Pixiong Su,Lei Zhao.Proteomic profiling of epicardial fat in heart failure with preserved versus reduced and mildly reduced ejection fraction[J].Journal of cellular and molecular medicine,2023,27(5):727-735.

[17]Iron deficiency in patients of heart failure with reduced ejection fraction[J].Medical Journal Armed Forces India

[18]莫新玲,李全忠,吴志伟,何学恕.Clinical characteristics analysis of heart failure with reduced ejection fraction and heart failure with reserved ejection fraction[J].Acta Medicinae Sinica,2014,27(6):31-35.

[19]CHEN Cun-fang,JIA Bo,JIANG Shan,JIANG Shuai.Clinical effect and prognosis of sacubitril-valsartan in treating heart failure patients with midrange ejection fraction[J].Chinese Journal of New Drugs and Clinical Remedies,2020(2):88-92.

[20]SU Jin-feng,CHEN Jun.The relationship among Cys C and heart function and prognosis in heart failure patients with preserved ejection fraction[J].Journal of Difficult and Complicated Cases,2013(8):587-589.